The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-((5-chloro-2-((2-methoxy-4-(3-(4-oxocyclohexyl)ureido)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acetamide ID: ALA4546844
Chembl Id: CHEMBL4546844
PubChem CID: 155552610
Max Phase: Preclinical
Molecular Formula: C26H28ClN7O4
Molecular Weight: 538.01
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(NC(=O)NC2CCC(=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1
Standard InChI: InChI=1S/C26H28ClN7O4/c1-15(35)29-20-5-3-4-6-21(20)32-24-19(27)14-28-25(34-24)33-22-12-9-17(13-23(22)38-2)31-26(37)30-16-7-10-18(36)11-8-16/h3-6,9,12-14,16H,7-8,10-11H2,1-2H3,(H,29,35)(H2,30,31,37)(H2,28,32,33,34)
Standard InChI Key: SNYQSPGQFDKITH-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 538.01Molecular Weight (Monoisotopic): 537.1891AlogP: 5.22#Rotatable Bonds: 8Polar Surface Area: 146.37Molecular Species: NEUTRALHBA: 8HBD: 5#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 3CX Acidic pKa: 12.67CX Basic pKa: 3.19CX LogP: 3.63CX LogD: 3.63Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.26Np Likeness Score: -1.37
References 1. Lei H, Jia F, Cao M, Wang J, Guo M, Zhu M, Zuo D, Zhai X.. (2019) An exploration of solvent-front region high affinity moiety leading to novel potent ALK & ROS1 dual inhibitors with mutant-combating effects., 27 (20): [PMID:31492532 ] [10.1016/j.bmc.2019.115051 ]